ArticleCell death & disease2025

CHK1 inhibition increases the therapeutic response to radiotherapy via antitumor immunity in ARID1A-deficient colorectal cancer.

Jhen-Yu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.